Knowing the kind of receptor on the cell for which the medicine will be targeted and using cell-specific ligands will enable the nanoparticle to attach exclusively to the cell that has the corresponding receptor. Cellular targeting is one method to actively target just sick tissue in the body. Intracellular delivery, a long-researched area in contemporary biotechnology, allows for effective medication administration into a variety of cell types. It is a crucial step in several cellular-level investigations, including gene delivery for gene editing and a number of biological research applications.
a. Targeted Drug Delivery System:   A targeted drug delivery system is a specialised type of medication administration in which the drug is only delivered at the site of action and not to the target organs, tissues, or cells.
b. Drug Targeting and Design: The capacity of a drug to acquire in the target tissue or organ particularly, so that the concentration of drug will be high at the illness, while its concentration is low in non-target organs and tissues, preferably below the certain minimal level to prevent any toxic effects, is referred to as drug targeting.
The non-specific harmful impact of traditional medication administration can be reduced using drug targeting. Another name for drug design is rational drug design or just rational design.
Title : The impact of metal-decorated polymeric nanodots on proton relaxivity
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, Universities of Alberta and Ottawa, Canada
Title : Exploring classical ayurvedic drugs in hypertension
Prashant Bhokardankar, Datta Meghe Ayurved College, India
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model based on design-inspired biotech- & biopharma-driven applications to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : A unique role and and impact of catalytic antibodies (abzymes) in clinical practice: A novel strategy for predicting and preventing relapse in chronic autoimmune conditions
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : The promise of nanotechnology in personalized & precision medicine: Drug discovery & development being partnered with nanotechnologies via the revolution at the nanoscale
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : The promising future of the unique translational tool to manage beta-cell population renewal and regeneration to secure the post-diabetic period
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Easily injectable, organic solvent free self assembled hydrogel platform for endoscope mediated gastrointestinal polypectomy
Hitasha Vithalani , IIT Gandhinagar, India
Title : Bridging tradition and innovation: Inorganic meets green synthesis
Maria Cristina Gamberini, University of Modena e Reggio Emilia, Italy